These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 15975013)
41. Noninvasive Imaging Reveals Stable Transgene Expression in Mouse Airways After Delivery of a Nonintegrating Recombinant Adeno-Associated Viral Vector. Vidović D; Gijsbers R; Quiles-Jimenez A; Dooley J; Van den Haute C; Van der Perren A; Liston A; Baekelandt V; Debyser Z; Carlon MS Hum Gene Ther; 2016 Jan; 27(1):60-71. PubMed ID: 26567984 [TBL] [Abstract][Full Text] [Related]
42. Novel tools for production and purification of recombinant adenoassociated virus vectors. Grimm D; Kern A; Rittner K; Kleinschmidt JA Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273 [TBL] [Abstract][Full Text] [Related]
43. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Grimm D; Kay MA Curr Gene Ther; 2003 Aug; 3(4):281-304. PubMed ID: 12871018 [TBL] [Abstract][Full Text] [Related]
44. Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males. Arruda VR; Fields PA; Milner R; Wainwright L; De Miguel MP; Donovan PJ; Herzog RW; Nichols TC; Biegel JA; Razavi M; Dake M; Huff D; Flake AW; Couto L; Kay MA; High KA Mol Ther; 2001 Dec; 4(6):586-92. PubMed ID: 11735343 [TBL] [Abstract][Full Text] [Related]
45. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Grieger JC; Samulski RJ Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890 [TBL] [Abstract][Full Text] [Related]
46. Parvovirus-mediated gene transfer for the haemophilias. Walsh CE; Chao H Haemophilia; 2002 Mar; 8 Suppl 2():60-7. PubMed ID: 11966856 [TBL] [Abstract][Full Text] [Related]
47. A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Aitken ML; Moss RB; Waltz DA; Dovey ME; Tonelli MR; McNamara SC; Gibson RL; Ramsey BW; Carter BJ; Reynolds TC Hum Gene Ther; 2001 Oct; 12(15):1907-16. PubMed ID: 11589832 [TBL] [Abstract][Full Text] [Related]
48. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma. Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631 [TBL] [Abstract][Full Text] [Related]
49. Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial. Vandamme C; Adjali O; Mingozzi F Hum Gene Ther; 2017 Nov; 28(11):1061-1074. PubMed ID: 28835127 [TBL] [Abstract][Full Text] [Related]
51. Recombinant adeno-associated virus for muscle directed gene therapy. Fisher KJ; Jooss K; Alston J; Yang Y; Haecker SE; High K; Pathak R; Raper SE; Wilson JM Nat Med; 1997 Mar; 3(3):306-12. PubMed ID: 9055858 [TBL] [Abstract][Full Text] [Related]
52. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. Yan Z; Zak R; Luxton GW; Ritchie TC; Bantel-Schaal U; Engelhardt JF J Virol; 2002 Mar; 76(5):2043-53. PubMed ID: 11836382 [TBL] [Abstract][Full Text] [Related]
53. Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice. Nakai H; Fuess S; Storm TA; Muramatsu S; Nara Y; Kay MA J Virol; 2005 Jan; 79(1):214-24. PubMed ID: 15596817 [TBL] [Abstract][Full Text] [Related]
54. Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments. Guggino WB; Cebotaru L Expert Opin Biol Ther; 2017 Oct; 17(10):1265-1273. PubMed ID: 28657358 [TBL] [Abstract][Full Text] [Related]
55. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV. Fan PD; Dong JY Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of risks related to the use of adeno-associated virus-based vectors. Tenenbaum L; Lehtonen E; Monahan PE Curr Gene Ther; 2003 Dec; 3(6):545-65. PubMed ID: 14683451 [TBL] [Abstract][Full Text] [Related]
58. Infectivity of adeno-associated virus serotypes in mouse testis. Rajasekaran S; Thatte J; Periasamy J; Javali A; Jayaram M; Sen D; Krishnagopal A; Jayandharan GR; Sambasivan R BMC Biotechnol; 2018 Nov; 18(1):70. PubMed ID: 30384832 [TBL] [Abstract][Full Text] [Related]
59. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Halbert CL; Allen JM; Miller AD Nat Biotechnol; 2002 Jul; 20(7):697-701. PubMed ID: 12089554 [TBL] [Abstract][Full Text] [Related]
60. Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes. Arnold GS; Sasser AK; Stachler MD; Bartlett JS Mol Ther; 2006 Jul; 14(1):97-106. PubMed ID: 16624620 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]